Emma N. Somerville

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Journal: Journal of Parkinson's disease

Published: August 06, 2026

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.

Journal: Research square

Published: July 17, 2026

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 18, 2026

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Lack of genetic evidence for a role of SLC25A46 in alpha-synucleinopathies.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.

Journal: medRxiv : the preprint server for health sciences

Published: January 08, 2026

No Evidence for Genetic Role of the Tumor Necrosis Factor Pathway in Parkinson's Disease.

No Evidence for Genetic Role of the Tumor Necrosis Factor Pathway in Parkinson's Disease.

Journal: medRxiv : the preprint server for health sciences

Published: September 18, 2025

No evidence for genetic role of the tumor necrosis factor pathway in Parkinson's disease.

No evidence for genetic role of the tumor necrosis factor pathway in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 06, 2025

No evidence for genetic role of the tumor necrosis factor pathway in Parkinson's disease.

No evidence for genetic role of the tumor necrosis factor pathway in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 06, 2025

MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS.

MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026